<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Russian Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-2106</issn><issn publication-format="electronic">2412-9100</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">38486</article-id><article-id pub-id-type="doi">10.18821/0869-2106-2018-24-6-310-315</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">ABNORMALITY IN LEARNING ON THE MODEL OF PARKINSON-LIKE SYNDROME: THE CORRECTABILITY BY THYMUS PEPTIDES</article-title><trans-title-group xml:lang="ru"><trans-title>ВОЗМОЖНОСТЬ КОРРЕКЦИИ ПЕПТИДАМИ ТИМУСА НАРУШЕНИЙ ОБУЧЕНИЯ НА МОДЕЛИ ПАРКИНСОНОПОДОБНОГО СИНДРОМА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korolev</surname><given-names>A. G</given-names></name><name xml:lang="ru"><surname>Королев</surname><given-names>А. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novoseletskaya</surname><given-names>A. V</given-names></name><name xml:lang="ru"><surname>Новоселецкая</surname><given-names>А. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiseleva</surname><given-names>N. M</given-names></name><name xml:lang="ru"><surname>Киселева</surname><given-names>Н. М</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>24</volume><issue>6</issue><issue-title xml:lang="en">VOL 24, NO6 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 24, №6 (2018)</issue-title><fpage>310</fpage><lpage>315</lpage><history><date date-type="received" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ООО "Эко-Вектор"</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://medjrf.com/0869-2106/article/view/38486">https://medjrf.com/0869-2106/article/view/38486</self-uri><abstract xml:lang="en"><p>In recent times the question of the bidirectional interactions of the neuroendocrine and immune systems is studied quite actively, its mechanisms offer the opportunity to allow for optimization the therapy of several diseases, including Parkinson’s disease. The purpose of this work is to study the influence of peptide drugs derived from the body’s immune system, the thymus, for the avoidance test conditioning, both in health and in the model of Parkinson-like syndrome. The work was performed on 80 male Wistar rats weighing 300-350 g. The injection of thymosin fraction 5 and thymalin to animals corrects clinical traits and behavioral dysfunctions caused by the singular injection of the neurotoxin. It also facilitates conditioned active evasion response in rats, which is especially noticeable at the early stages of memory footprint formation.</p></abstract><trans-abstract xml:lang="ru"><p>В последнее время достаточно активно изучается вопрос двунаправленного взаимодействия нейроэндокринной и иммунной систем, механизмы которого дают возможность для оптимизации терапии ряда заболеваний, в том числе болезни Паркинсона. Цель данной работы состоит в исследовании влияния пептидных препаратов, полученных из органа иммунной системы - тимуса, на выработку условного рефлекса активного избегания, как в норме, так и в модели паркинсоноподобного синдрома. Работа была выполнена на 80 самцах крыс Wistar массой 300-350 г. Введение тималина и тимозина фракции 5 животным корректирует у них клинические проявления и поведенческие нарушения, вызванные однократным введением нейротоксина, и ускоряет выработку условного рефлекса активного избегания у крыс, что ярко выражено на начальных этапах формирования памятного следа.</p></trans-abstract><kwd-group xml:lang="en"><kwd>memory</kwd><kwd>parkinson’s disease</kwd><kwd>thymalin</kwd><kwd>thymosin fraction 5</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>память</kwd><kwd>болезнь Паркинсона</kwd><kwd>тималин</kwd><kwd>тимозин фракция 5</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Yong V.W., Rivest S. Taking advantage of the systemic immune system to cure brain diseases. Neuron. 2009; 64 (1): 55-60.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Denes A., Thornton P., Rothwell N.J. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 2010; 24 (5): 708-23.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Dinarello C.A. IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 2010; 40 (3): 599-606.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Giles J.A., Greenhalgh A.D., Davies C.L. et al. Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity. Eur. J. Immunol. 2015; 45 (2): 525-30.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Захарова Л.А. Пластичность нейроэндокринной и иммунной систем в раннем развитии. Известия РАН. 2014; 5: 437-47.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Thyagarajan S., Priyanka H.P. Bidirectional communication between the neuroendocrine system and the immune system: relevance to health and diseases. Annals of Neurosciences. 2012; 19 (1): 40-6.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Demas G.E., Carlton E.D. Ecoimmunology for psychoneuroimmunologists: Considering context in neuroendocrine-immune-behavior interactions. Brain Behav. Immun. 2015; 44: 9-16.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Akiyama H. Inflammation and Alzheimer’s disease. Neurobiol. Aging. 2000; 21: 383-421.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Frank L.H., Richard M., Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nature Reviews Neurosci. 2015; 16: 358-72.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Chai Q., He W.Q., Zhou M. et al. Enhancement of bloodbrain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J. Virol. 2014; 88 (9): 4698-710.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Reggiani P.C., Schwerdt J.I., Console G.M. et al. Physiology and Therapeutic Potential of the Thymic Peptide Thymulin. Curr. Pharm. Des. 2014; 20 (29): 4690-6.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Reggiani P.C., Martines E.V., Camihort G.A. et.al. Role of thymulin on the somatotropic axis in vivo. Life Sci. 2012; 91 (5-6): 166-71.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Новоселецкая А.В., Киселева Н.М., Иноземцев и др. Влияние экстракта тимуса тактивина на формирование пищевого условного рефлекса у крыс. Росс. иммунол. журн. 2010; 4(вып. 1): 83-7.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Яковлев Г.М., Новиков В.С., Смирнов В.С. и др. Механизмы биорегуляции. СПб.: Наука; 1992.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Prediger R.D., Batista L.C., Medeiros R. et al. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson’s disease. Exp. Neurology. 2006; 202: 391-403.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Castro A.A., Wiemes B.P., Matheus F.C. et al. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson’s disease. Journ. Brain Research. 2013; 1513: 103-16.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Буреш Я., Бурешова О., Хьюстон Дж.П. Методики и основные эксперименты по изучению мозга и поведения. М.: Высшая школа; 1991.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Киселева Н.М., Новоселецкая А.В., Зимина И.В. и др. Влияние тактивина на поведение и обучение крыс. Вестн. Росс. акад. мед. наук. 2010; 1: 23-6.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Киселева Н.М., Новоселецкая А.В., Воеводина Е.Б. и др. Количественная оценка обучения и памятного следа при изучении мнемотропных свойств иммунотропных препаратов. Бюлл. эксп. биол. и мед. 2012; 154 (8): 197-201.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Schwartz M., Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. The EMBO J. 2014; 33 (1): 7-22.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Monahan A.J., Carvey P.M. Neuroinflammation and Peripheral Immune Infiltration in Parkinson’s disease: An autoimmune hypothesis. Cell Transplantation. 2008; 17: 1-10.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>McGeer P.L., McGeer E.G. Glial reactions in Parkinson’s disease. Mov. Disord. 2008; 23 (4): 474-83.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kurkowska-Jastrzebska I., Wrońska A., Kohutnicka M. et al. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 1999; 156: 50-61.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Teismann P., Tieu K., Choi D. et al. Cyclooxygenase-2 is instrumental in Parkinson’s disease neurodegeneration. Proc. Natl. Acad. Sci. USA. 2003; 100: 5473-8.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Bas J., Calopa M., Mestre M. et al. Lymphocyte populations in Parkinson’s disease and in rat models of Parkinsonism. J. Neuroimmunol. 2001; 113: 146-52.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Reynolds A.D., Banerjee R., Liu J. et al. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease. J. Leukoc. Biol. 2007; 82 (5): P. 1083-94.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Reynolds A.D., Stone D.K., Mosley R.L., Gendelman H.E. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J. Immunol. 2009; 182 (7): 4137-49.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Liu J., Gong N., Huang X. et al. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model ofHIV-1-associated neurodegeneration. J. Immunol. 2009; 182: 3855-65.</mixed-citation></ref></ref-list></back></article>
